The CHEK2 I157T Variant and Colorectal Cancer Susceptibility: A Systematic Review and Meta-analysis
Authors:
- Qing-Shui WangQWQing-Shui Wang
- Ya-Jie WangYWYa-Jie Wang
Open Access
- 30 May 2012
- journal article
- review article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 13 (5) , 2051-2055
Abstract
The cell cycle checkpoint kinase 2 (CHEK2) gene I157T variant may be associated with an increased risk of colorectal cancer, but it is unclear whether the evidence is sufficient to recommend testing for the mutation in clinical practice. We systematically searched PubMed, EMBASES, Elsevier and Springer for relevant articles before Apr 2012. Summary odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated using a fixed-effects or random-effects models with Review Manager 5.0 software. A total of seven studies including 4,029 cases and 13,844 controls based on the search criteria were included for analysis. A significant association of the CHEK2 I157T C variant with unselected CRC was found (OR=1.61, 95% CI=1.40-1.87, P<0.001). We also found a significant association with sporadic CRC (OR=1.48, 95% CI=1.23-1.77, P<0.001) and separately with familial CRC (OR=1.97, 95% CI=1.41-2.74, P<0.001). This meta-analysis demonstrates that the CHEK2 I157T variant may be another important CRC-predisposing gene, which increases CRC risk, especially in familial CRC.Keywords
This publication has 36 references indexed in Scilit:
- Characterization of Gene–Environment Interactions for Colorectal Cancer Susceptibility LociCancer Research, 2012
- Body Mass Index and Risk of Colorectal Cancer According to Fatty Acid Synthase Expression in the Nurses’ Health StudyJNCI: Journal of the National Cancer Institute, 2012
- Red meat consumption and cancer: Reasons to suspect involvement of bovine infectious factors in colorectal cancerInternational Journal of Cancer, 2011
- Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancerBreast Cancer Research and Treatment, 2011
- Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?European Journal of Human Genetics, 2006
- Pilot Study on Low Penetrance Breast and Colorectal Cancer Predisposition Markers in LatviaHereditary Cancer in Clinical Practice, 2006
- CHEK2 Is a Multiorgan Cancer Susceptibility GeneThe American Journal of Human Genetics, 2004
- CHEK2 variant I157T may be associated with increased breast cancer riskInternational Journal of Cancer, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986